DOMH Insider Trading

Insider Ownership Percentage: 8.60%
Insider Buying (Last 12 Months): $145,299.98
Insider Selling (Last 12 Months): $0.00

Dominari Insider Trading History Chart

This chart shows the insider buying and selling history at Dominari by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Dominari Share Price & Price History

Current Price: $2.58
Price Change: Price Increase of +0.07 (2.79%)
As of 06/2/2023 01:00 AM ET

This chart shows the closing price history over time for DOMH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Dominari Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/30/2023Kyle Michael WoolDirectorBuy2,000$2.59$5,180.00280,850View SEC Filing Icon  
5/24/2023Anthony HayesCEOBuy2,000$2.75$5,500.00212,681View SEC Filing Icon  
5/18/2023Kyle Michael WoolDirectorBuy2,000$2.94$5,880.00278,792View SEC Filing Icon  
5/16/2023Anthony HayesCEOBuy2,000$2.77$5,540.00208,681View SEC Filing Icon  
4/5/2023Christopher Franklin DevallCOOBuy5,698$3.51$19,999.9819,533View SEC Filing Icon  
4/4/2023Anthony HayesCEOBuy30,000$3.44$103,200.00206,681View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Dominari (NASDAQ:DOMH)

10.88% of Dominari stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Dominari logo
Dominari Holdings, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.
Read More on Dominari

Today's Range

Now: $2.58
Low: $2.51
High: $2.60

50 Day Range

MA: $3.12
Low: $2.33
High: $3.76

52 Week Range

Now: $2.58
Low: $2.06
High: $7.27


5,738 shs

Average Volume

23,786 shs

Market Capitalization

$11.84 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Dominari?

Dominari's top insider investors include:
  1. Kyle Michael Wool (Director)
  2. Anthony Hayes (CEO)
  3. Christopher Franklin Devall (COO)
Learn More about top insider investors at Dominari.